Bing

Momenta Pharmaceuticals (NASDAQ: MNTA) – Wheeler Craig sold 1,766 stocks at $22.28 ... NOTE: Information with regards the stock market’s insider selling activity as shown on this page have been generated on …
Fx Pips · 8/26/2015
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Momenta Pharmaceuticals Inc. (MNTA). This Medicine–Biomedicine/Genetic stock has actually seen estimates rise over the past month for the ...
Yahoo Finance · 8/18/2015
Momenta Pharmaceuticals (NASDAQ:MNTA) President Craig A. Wheeler sold 1,766 shares of the stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $22.28, for a total value of $39,346.48. Following …
Watch List News · 8/26/2015
Looking back to 84 days ago, Momenta Pharmaceuticals Inc (Symbol: MNTA) priced a 7,250,000 share secondary stock offering at $19.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment …
NASDAQ · 8/11/2015
A regulatory nod has sent Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) soaring, with the stock peaking north of $20 for the first time in three years. MNTA was last seen 9.3% higher at $17.59, and option buyers are betting bullishly. Call volume has ...
Schaeffer's Investment Research · ByAndrea Kramer · 4/16/2015
Investors in Momenta Pharmaceuticals Inc (NASDAQ:MNTA) saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNTA options chain for the new …
Market News Video · 8/28/2011
Momenta (NASDAQ:MNTA) is a small biotech with a market capitalization of about $1.5 billion. The company focuses on developing generics of complex medications. The stock has doubled in value over the past six months, mostly due to the FDA's …
Seeking Alpha · 8/4/2015
The stock has more than doubled in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNTA at http://www.zacks.
NBC News · 8/4/2015
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNTA at http://www.zacks.com/ap/MNTA Keywords: Momenta Pharmaceuticals, Earnings Report
Yahoo Singapore Finance · 8/4/2015
Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) announced top-line results from the EMINENCE (Evaluation of M118 in Percutaneous Coronary Intervention) phase 2 multicenter study of the intravenous formulation of M118. EMINENCE was designed to …
StreetInsider · 6/29/2009